BHT (butylated hydroxytoluene) --
Additional Notes 1
John A. Mann / Steven W. Fowkes
book published scientific evidence strongly suggests that
BHT might help in treating AIDS (acquired immune deficiency syndrome) or ARC
(early stages of AIDS), as well as certain opportunistic infections,
especially CMV (cytomegalovirus), and that the risks may be kept small. It has
shown promise on
every other lipid-coated virus on which it has been tried. The only human antiviral test, topical use,
was also showed positive results.
But we don't know with certainty whether BHT will help
for AIDS or ARC, because research has been limited, either in the laboratory or with
patients. An unknown number of people are using BHT for AIDS or ARC on their own, but
there is no way to contact them, and many don't want to talk publicly. For
CMV, often a
major problem with AIDS/ARC, there is more evidence that BHT may be supportive, as it has
been tested against the virus in the laboratory and worked well; however, there are
currently no published human studies.
No one expects BHT to be a cure.
But, if it can help in
the management of AIDS and/or CMV, it would have value now until better treatments become
background information on BHT as an antiviral or for life extension,
contact the MegaHealth
Society, 994 Acacia Ave., Los Altos, CA 94022. The MegaHealth
Society serves as a clearinghouse for BHT information. It also publishes a quarterly
newsletter, which will include new developments in the use of BHT for herpes and for AIDS.
Page 1 |
| Additional Notes
(butylated hydroxytoluene, hydroxy toluene) |
Paniculata | Vitamin D3 |
| Colloidal Silver |
Immune (System) Protect
Beta 1,3/1,6 D Glucan